Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study
Abstract Background In critically ill patients, drug incompatibilities frequently occur because of the number of drugs to be administered through a limited number of infusion lines. These are among the main causes of particulate contamination. However, little data is available to quantify particle e...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-10-01
|
Series: | Intensive Care Medicine Experimental |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40635-018-0205-2 |
id |
doaj-0981219dbabf414f875db87848fe4b38 |
---|---|
record_format |
Article |
spelling |
doaj-0981219dbabf414f875db87848fe4b382020-11-25T01:18:34ZengSpringerOpenIntensive Care Medicine Experimental2197-425X2018-10-01611910.1186/s40635-018-0205-2Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro studyMalik Benlabed0Anthony Martin Mena1Romain Gaudy2Maxime Perez3Stéphanie Genay4Jean-Daniel Hecq5Pascal Odou6Gilles Lebuffe7Bertrand Décaudin8Univ. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesDepartment of Pharmacy, CHU UCL NamurUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesUniv. Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies AssociéesAbstract Background In critically ill patients, drug incompatibilities frequently occur because of the number of drugs to be administered through a limited number of infusion lines. These are among the main causes of particulate contamination. However, little data is available to quantify particle exposure during simultaneous IV-drug infusion. The objective of this study was to evaluate the particulate matter potentially administered to critically ill patients. Methods The particulate matter (between 1 μm and 30 mm) of infused therapies used in ICUs for patients suffering from either septic shock or acute respiratory distress syndrome was measured in vitro over 6 h using a dynamic image analysis device, so that both overall particulate contamination and particle sizes could be determined. Data is presented according to the recommendations of the European Pharmacopoeia (≥ 10 and 25 μm). Results For the six experimental procedures (continuous infusion of norepinephrine, midazolam, sufentanil, heparin, 5% glucose, binary parenteral nutrition and discontinuous administrations of omeprazole, piperacillin/tazobactam and fluconazole), the overall number of particles over the 6-h infusion period was 8256 [5013; 15,044]. The collected values for the number of particles ≥ 10 and 25 μm were 281 [118; 526] and 19 [7; 96] respectively. Our results showed that discontinuous administrations of drugs led to disturbances in particulate contamination. Conclusions This work indicates the amount of particulate matter potentially administered to critically ill adult patients. Particulate contamination appears lower than previous measurements performed during multidrug IV therapies in children.http://link.springer.com/article/10.1186/s40635-018-0205-2Parenteral nutritionIntravenousInfusion pumpsDrug incompatibilityCritical care |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Malik Benlabed Anthony Martin Mena Romain Gaudy Maxime Perez Stéphanie Genay Jean-Daniel Hecq Pascal Odou Gilles Lebuffe Bertrand Décaudin |
spellingShingle |
Malik Benlabed Anthony Martin Mena Romain Gaudy Maxime Perez Stéphanie Genay Jean-Daniel Hecq Pascal Odou Gilles Lebuffe Bertrand Décaudin Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study Intensive Care Medicine Experimental Parenteral nutrition Intravenous Infusion pumps Drug incompatibility Critical care |
author_facet |
Malik Benlabed Anthony Martin Mena Romain Gaudy Maxime Perez Stéphanie Genay Jean-Daniel Hecq Pascal Odou Gilles Lebuffe Bertrand Décaudin |
author_sort |
Malik Benlabed |
title |
Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study |
title_short |
Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study |
title_full |
Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study |
title_fullStr |
Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study |
title_full_unstemmed |
Analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study |
title_sort |
analysis of particulate exposure during continuous drug infusion in critically ill adult patients: a preliminary proof-of-concept in vitro study |
publisher |
SpringerOpen |
series |
Intensive Care Medicine Experimental |
issn |
2197-425X |
publishDate |
2018-10-01 |
description |
Abstract Background In critically ill patients, drug incompatibilities frequently occur because of the number of drugs to be administered through a limited number of infusion lines. These are among the main causes of particulate contamination. However, little data is available to quantify particle exposure during simultaneous IV-drug infusion. The objective of this study was to evaluate the particulate matter potentially administered to critically ill patients. Methods The particulate matter (between 1 μm and 30 mm) of infused therapies used in ICUs for patients suffering from either septic shock or acute respiratory distress syndrome was measured in vitro over 6 h using a dynamic image analysis device, so that both overall particulate contamination and particle sizes could be determined. Data is presented according to the recommendations of the European Pharmacopoeia (≥ 10 and 25 μm). Results For the six experimental procedures (continuous infusion of norepinephrine, midazolam, sufentanil, heparin, 5% glucose, binary parenteral nutrition and discontinuous administrations of omeprazole, piperacillin/tazobactam and fluconazole), the overall number of particles over the 6-h infusion period was 8256 [5013; 15,044]. The collected values for the number of particles ≥ 10 and 25 μm were 281 [118; 526] and 19 [7; 96] respectively. Our results showed that discontinuous administrations of drugs led to disturbances in particulate contamination. Conclusions This work indicates the amount of particulate matter potentially administered to critically ill adult patients. Particulate contamination appears lower than previous measurements performed during multidrug IV therapies in children. |
topic |
Parenteral nutrition Intravenous Infusion pumps Drug incompatibility Critical care |
url |
http://link.springer.com/article/10.1186/s40635-018-0205-2 |
work_keys_str_mv |
AT malikbenlabed analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy AT anthonymartinmena analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy AT romaingaudy analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy AT maximeperez analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy AT stephaniegenay analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy AT jeandanielhecq analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy AT pascalodou analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy AT gilleslebuffe analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy AT bertranddecaudin analysisofparticulateexposureduringcontinuousdruginfusionincriticallyilladultpatientsapreliminaryproofofconceptinvitrostudy |
_version_ |
1725141860502994944 |